The tool performs online identity checks against official data sources, matching it with biographic information from the ...

Lower survival rates in Black leukemia patients treated with intensive chemotherapy not linked to differences in genetic ...

The Ivanhoe Atlantic/HPX concession faces significant hurdles due to the lack of formal Guinean approval and unresolved issues regarding third-party rail access, particularly the involvement of AML.By ...

Compared with white patients, Black patients with an aggressive form of leukemia—called acute myeloid leukemia (AML)—were on ...

The mortality-to-incidence ratio initially increased in the early 2000s, declined sharply between 2008 and 2011, and remained stable thereafter.

Summary • Curis, Inc. stock jumped 8.6% in after-hours trading to $1.26 after positive clinical trial results for its AML treatment.• 62.5% of patients in the frontline study achieved undetectable ...

PRESS RELEASEAB SCIENCE ANNOUNCES A NEW PUBLICATION ON BIORXIV THAT IDENTIFIES AND CHARACTERIZES A NOVEL SMALL SYNTHETIC MOLECULE, AB8939, AS A ...

Results from the Precision-T study showed Orca-T significantly improved survival free from chronic GvHD in patients with AML, ALL and MDS compared to a conventional allogeneic hematopoietic stem cell ...

The American Society of Hematology/ASH 2025 meeting included AML results from AAML1831, MyeChild01, BIG-1, and PALG-AML1/2016 studies.

While patients with acute myeloid leukemia (AML) are routinely treated with chemotherapy and other cell-killing therapies, ...

DRC, Chad, and Equatorial Guinea rank as Africa’s most exposed countries in 2025 Only Botswana, Seychelles, and Mauritius fall into the low-risk category Sub-Saharan Africa shows broad improvement ...

November's wave of FDA oncology approvals signals the industry's shift toward platform-based precision therapies over broad-spectrum approaches([1]) . The global anticancer drug market now values ...